Search
for
Sort by
Research 931–960 of 1000+
- Salt-losing tubulopathy and chronic dermatitis
- Hair Loss in Youngsters
- A hedonic response to an assay made on octogenarians using cosmetics that promise to donate comfort, attractiveness and youth
- Advances in Aesthetic Therapies: Plasma-Rich Protein Procedure for the Treatment of Alopecia
- 559 Visualization of sweat suppression following botulinum toxin A by soluble microneedle arrays
- 556 α 1 -AR agonist induced piloerection protects against the development of traction alopecia
- 557 A peptide derivative with known anti-wrinkle properties was identified as potent dipeptiylpeptidase-4 inhibitor
- Pathologies of the skin and its appendages in endocrine diseases
- Clinical Snippets
- Clinical Snippets
- Mental, Behavioral And Physical Effects Of Power Enhancing Drugs In Chronic Users
- Hormonal Control of Cardiac Action Potential Phase 1 Currents in the Brugada Syndrome
- Estrogen induce VEGF expression in dermal papilla cells
- Reporting on Adverse Clinical Events
- Prostate cancer update: 2007
- New onset of alopecia in a young woman with end-stage renal disease
- Drug Discovery Today: Therapeutic Strategies - 2006 Editorial
- The successful treatment of nephrogenic fibrosing dermopathy (NFD) with mycophenolate mofetil (MMF)
- The prevalence of itch and pain and its characteristics in patients with mild to moderate insufficiency and its relationship to the degree of venous insufficiency
- The use of diphencyprone in dermatology: A retospective audit
- Their year at Parkland Memorial Hospital (2005)
- 13. Wound Healing & Hair
- 5. HIV, Fungal and Infectious Diseases
- 4. Bullous/Mucous Membrane
- 1. Medical Practice; Therapy; Adverse Reactions
- 12. Cancer
- Morphogenesis- and Hair Cycle-dependent Expression of Trichohyalin, Peptidylarginine Deiminase Type III and Deiminated Trichohyalin in Rat Dorsal Skin Hair Follicles
- Balding man.
- Self-medication by Jockeys
- Acute dermal and ocular irritation testing of rice bran supercritical CO2 extract (RB-SCE) and 0.5% RB-SCE essence product